Magnet.me - Het slimme netwerk waarop hbo‑ en wo‑studenten hun baan of stage vinden.
Het slimme netwerk waarop hbo‑ en wo‑studenten hun baan of stage vinden.
Je carrière begint op Magnet.me
Maak een profiel aan en ontvang slimme aanbevelingen op basis van je gelikete vacatures.
We are seeking an Assistant Professor to lead the Computer-Aided Drug Design (CADD) group within the Medicinal Chemistry division. The successful candidate will develop methodologies in molecular modeling, data management, and machine learning to advance the understanding of ligand-protein interactions.
With a background in drug development, medicinal chemistry, and computational chemistry, the candidate will support research on G-Protein Coupled Receptors and Fragment-Based Drug Discovery. The role requires expertise in both ligand-based and structure-based drug discovery, and the molecular insights obtained will help guide synthetic chemists and molecular pharmacologists through interdisciplinary collaboration within the division.
We welcome applications from individuals who recognize themselves in this profile, even if not all requirements are met.
A challenging position in a socially engaged organisation. At VU Amsterdam, you contribute to education, research, and service for a better world. In return for your efforts, we offer you:
A competitive salary ranging from € 4.332,00 to € 6.737,00 gross per month, based on experience and education.The Medicinal Chemistry Division
The group has two main research lines, G protein-coupled receptors (GPCRs) and Fragment-Based Drug Discovery. Within the GPCR research line, the division has been focusing especially on histamine receptors and chemokine receptors. The computational group uses the rapidly emerging structural understanding to develop GPCR activation models, construct ligand-protein binding models, deduce structure-activity relationships, and identify and optimize novel GPCR ligands.
Within the fragment-based drug design research line, molecular modeling explores various protein classes, including GPCRs, phosphodiesterases, and ligand-gated ion channels. Identification of fragment hits is followed up by structure-based drug design to develop potent lead compounds. Fragment-based approaches are also used to study fundamental aspects of ligand-protein binding using experimental data generated by techniques like SPR, ITC, and x-ray crystallography. Bio- and cheminformatics approaches are employed to study poly-pharmacology, aiming to develop new drug candidates with clinical potential, particularly for neglected parasitic diseases and inflammation.
Vrije Universiteit Amsterdam
VU Amsterdam stands for values-driven education and research. We are open-minded experts who think freely, maintaining an entrepreneurial perspective focused on diversity and social significance. Together, we aim for sustainable solutions with social impact. We foster a climate of safety, respect, and inspiration for education and research.
We are committed to diversity, recognizing it as crucial for outstanding teaching, research, and service quality. We invite people whose backgrounds and experiences contribute to the diversity of the VU community to apply.
Are you interested in this position and believe your experience will contribute to our university's development? We encourage you to submit your application.
Submitting a diploma and a reference check are part of the application process.
Applications received by e-mail will not be considered.
At Vrije Universiteit Amsterdam, we attach great importance to the societal impact of our education and research. Personal development and social involvement are key parts of our vision on education, in which individual differences are seen as a strength. This allows us to develop innovations and insights that contribute to a better world.
Resources:
Change language to: English
Deze pagina is geoptimaliseerd voor mensen uit Nederland. Bekijk de versie geoptimaliseerd voor mensen uit het Verenigd Koninkrijk.